BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8354742)

  • 1. Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
    McGrath PJ; Stewart JW; Tricamo E; Nunes EN; Quitkin FM
    J Clin Psychopharmacol; 1993 Jun; 13(3):224-5. PubMed ID: 8354742
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradoxical mood changes during pharmacotherapy of bipolar patients.
    Kusalic M; Ghadirian AM
    Biol Psychiatry; 1990 May; 27(10):1183-4. PubMed ID: 2340327
    [No Abstract]   [Full Text] [Related]  

  • 3. Mania or hypomania after withdrawal from antidepressants.
    Hartmann PM
    J Fam Pract; 1990 Apr; 30(4):471-2. PubMed ID: 2324698
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors associated with premature medication discontinuation among responders to an MAOI or a tricyclic antidepressant.
    Agosti V; Stewart JW; Quitkin FM; Rabkin JG; McGrath PJ; Markowitz J
    J Clin Psychiatry; 1988 May; 49(5):196-8. PubMed ID: 3366755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled study of the effects of antidepressants on sexual function.
    Harrison WM; Stewart J; Ehrhardt AA; Rabkin J; McGrath P; Liebowitz M; Quitkin FM
    Psychopharmacol Bull; 1985; 21(1):85-8. PubMed ID: 3885294
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression.
    Agosti V; Stewart JW
    Int Clin Psychopharmacol; 2007 Sep; 22(5):309-11. PubMed ID: 17690600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast-cycling bipolar disorder induced by withdrawal from long-term treatment with a tricyclic antidepressant.
    Jones BD; Steinberg S; Chouinard G
    Am J Psychiatry; 1984 Jan; 141(1):108-9. PubMed ID: 6691424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-induced rapid cycling: six case reports.
    Hurowitz GI; Liebowitz MR
    J Clin Psychopharmacol; 1993 Feb; 13(1):52-6. PubMed ID: 8486818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
    McGrath PJ; Stewart JW; Nunes EV; Ocepek-Welikson K; Rabkin JG; Quitkin FM; Klein DF
    Am J Psychiatry; 1993 Jan; 150(1):118-23. PubMed ID: 8417553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomania related to phenelzine and isoetharine interaction in one patient.
    Goldman LS; Tiller JA
    J Clin Psychiatry; 1987 Apr; 48(4):170. PubMed ID: 3558333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attrition and its consequences in a clinical trial of placebo, imipramine, and phenelzine.
    Markowitz JS; Rabkin JG; McGrath PJ; Stewart J; Quitkin FM
    Psychopharmacol Bull; 1985; 21(1):107-9. PubMed ID: 3885288
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypomania and mania after withdrawal of tricyclic antidepressants.
    Mirin SM; Schatzberg AF; Creasey DE
    Am J Psychiatry; 1981 Jan; 138(1):87-9. PubMed ID: 7446789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
    Rabkin JG; Markowitz JS; Stewart J; McGrath P; Harrison W; Quitkin FM; Klein DF
    Psychiatry Res; 1986 Sep; 19(1):75-86. PubMed ID: 3538107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-withdrawal mania:a critical review and synthesis of the literature.
    Andrade C
    J Clin Psychiatry; 2004 Jul; 65(7):987-93. PubMed ID: 15291689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Harrison W; Quitkin FM
    Psychopharmacol Bull; 1987; 23(1):169-72. PubMed ID: 3602314
    [No Abstract]   [Full Text] [Related]  

  • 18. Undue mood elevation in unipolar patients following cessation of lithium augmentation treatment: implications for the understanding of mood disorders.
    Hoaken PC; Hoaken P
    Can J Psychiatry; 1996 Feb; 41(1):46-8. PubMed ID: 8919423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mania induced by gradual withdrawal from long-term treatment with imipramine.
    Gupta R; Narang RL
    Am J Psychiatry; 1986 Feb; 143(2):260. PubMed ID: 3946672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.